Target Details
| UniProt AC | Q07889 |
|---|---|
| Gene Symbol | SOS1 |
| Protein Name | Son of sevenless homolog 1 |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF00617 (RasGEF) PF00618 (RasGEF_N) PF00621 (RhoGEF) PF22697 (SOS1_NGEF_PH) |
Summary
- Multi-target molecules 766
- Clinical molecules 0
- Avg pChEMBL 8.12
KEGG Pathways (48)
- Acute myeloid leukemia
- Alcoholism
- B cell receptor signaling pathway
- Breast cancer
- Chemical carcinogenesis - reactive oxygen species
- Chemical carcinogenesis - receptor activation
- Chemokine signaling pathway
- Choline metabolism in cancer
- Chronic myeloid leukemia
- Colorectal cancer
- EGFR tyrosine kinase inhibitor resistance
- Endocrine resistance
- Endometrial cancer
- ErbB signaling pathway
- Estrogen signaling pathway
- Fc epsilon RI signaling pathway
- Focal adhesion
- FoxO signaling pathway
- Gap junction
- Gastric cancer
- Glioma
- GnRH signaling pathway
- Growth hormone synthesis, secretion and action
- Hepatitis B
- Hepatitis C
- Hepatocellular carcinoma
- Human cytomegalovirus infection
- Human papillomavirus infection
- Insulin signaling pathway
- JAK-STAT signaling pathway
- MAPK signaling pathway
- MicroRNAs in cancer
- Natural killer cell mediated cytotoxicity
- Neurotrophin signaling pathway
- Non-small cell lung cancer
- PI3K-Akt signaling pathway
- Pathways in cancer
- Phospholipase D signaling pathway
- Prolactin signaling pathway
- Prostate cancer
- Proteoglycans in cancer
- Ras signaling pathway
- Regulation of actin cytoskeleton
- Relaxin signaling pathway
- Renal cell carcinoma
- T cell receptor signaling pathway
- Thermogenesis
- mTOR signaling pathway
Associated Diseases (3)
Active Molecules (766)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
AANJEUXUIQSWKZ
|
8.3 | IC50 | 2 | — | |
BPUGJDAQXBLEES
|
8.3 | IC50 | 2 | — | |
BYQYOMNLRMYUEC
|
8.3 | IC50 | 2 | — | |
CZCVSZZSFGXQLW
|
8.3 | IC50 | 2 | — | |
DRUFCMMPLWFUBQ
|
8.3 | IC50 | 2 | — | |
GUHFGWCGJHNAJB
|
8.3 | IC50 | 2 | — | |
HMJSRGGPCPSTFE
|
8.3 | IC50 | 2 | — | |
IGPJSZXNUNGNKF
|
8.3 | IC50 | 2 | — | |
IPMGDODXDXGTOU
|
8.3 | IC50 | 2 | — | |
IYAWBENCGGFNSA
|
8.3 | IC50 | 2 | — | |
JUBMDAWPXHPIIG
|
8.3 | IC50 | 2 | — | |
KPQFHWXCYXLBMW
|
8.3 | IC50 | 2 | — | |
LJTJIUYTAZPUMG
|
8.3 | IC50 | 2 | — | |
NPFWDQYMNIFZAH
|
8.3 | IC50 | 2 | — | |
OIXVIIXAMVIVCA
|
8.3 | IC50 | 2 | — | |
OPWSDOPRIRMMJL
|
8.3 | IC50 | 2 | — | |
PFVSIRXFLKJLIZ
|
8.3 | IC50 | 2 | — | |
PGZRUXNDNBCLKM
|
8.3 | IC50 | 2 | — | |
QDICKPSRQPBGQB
|
8.3 | IC50 | 2 | — | |
QNOGRPYNMSQJNO
|
8.3 | IC50 | 2 | — | |
RVIBMYNEVGUCHR
|
8.3 | IC50 | 2 | — | |
UOBFXQNHIQCRON
|
8.3 | IC50 | 2 | — | |
WWBFYVLHBJAVQY
|
8.3 | IC50 | 2 | — | |
XDGNADLKDBEEKV
|
8.3 | IC50 | 2 | — | |
XKXQISLRGDJBDO
|
8.3 | IC50 | 2 | — | |
XLGFKBBJACUOTO
|
8.3 | IC50 | 2 | — | |
XVBIRTPPRYRRNK
|
8.3 | IC50 | 2 | — | |
XVFDNRYZXDHTHT
|
8.3 | IC50 | 2 | — | |
ZCXDDJLWNVDNIJ
|
8.3 | IC50 | 2 | — | |
NMQCIPHVFNLYPH
|
8.3 | IC50 | 2 | — | |
WWPDTHZEUSKWON
|
8.3 | IC50 | 2 | — | |
GSZLBBQYAQRWAD
|
8.2 | IC50 | 2 | — | |
XYDZNPJUGCIGFJ
|
8.2 | IC50 | 2 | — | |
BDXGWNHWDLCGOI
|
8.2 | IC50 | 2 | — | |
BJOXDJMEJPDZCU
|
8.2 | IC50 | 2 | — | |
BPUGJDAQXBLEES
|
8.2 | IC50 | 2 | — | |
CGLYBDGNPMRTJZ
|
8.2 | IC50 | 2 | — | |
CVRPUZUESSHZPE
|
8.2 | IC50 | 2 | — | |
DRKFKMCMFBMNPX
|
8.2 | IC50 | 2 | — | |
FIVGYKZOFDQULT
|
8.2 | Kd | 2 | — | |
FRJGHWCMERVQNX
|
8.2 | IC50 | 2 | — | |
HEQVVKVDXMCMSP
|
8.2 | IC50 | 2 | — | |
HOBMIIXUHKCELA
|
8.2 | IC50 | 2 | — | |
IAGUIIJYYGVGCI
|
8.2 | IC50 | 2 | — | |
IXYGGZPQRHHYIE
|
8.2 | Kd | 2 | — | |
JQVZOLGRNHXXQB
|
8.2 | IC50 | 2 | — | |
MAJUYKNHKWNXDO
|
8.2 | Kd | 2 | — | |
MKVZEYRATUAOJA
|
8.2 | IC50 | 2 | — | |
MMJKRGBFAKFREC
|
8.2 | IC50 | 2 | — | |
MXGIIWMIWNCVGR
|
8.2 | IC50 | 2 | — |